APA (7th ed.) Citation

R, L., LL, S., S, M., EJ, K., D, P., S, A., . . . VA, M. (2026). Laboratory paraneoplastic syndrome resolution is associated with reduced recurrence and improved survival in non-metastatic renal cell carcinoma. Urologic oncology, 44(6), 128. https://doi.org/10.1016/j.urolonc.2026.111093

Chicago Style (17th ed.) Citation

R, Lahiji, et al. "Laboratory Paraneoplastic Syndrome Resolution Is Associated with Reduced Recurrence and Improved Survival in Non-metastatic Renal Cell Carcinoma." Urologic Oncology 44, no. 6 (2026): 128. https://doi.org/10.1016/j.urolonc.2026.111093.

MLA (9th ed.) Citation

R, Lahiji, et al. "Laboratory Paraneoplastic Syndrome Resolution Is Associated with Reduced Recurrence and Improved Survival in Non-metastatic Renal Cell Carcinoma." Urologic Oncology, vol. 44, no. 6, 2026, p. 128, https://doi.org/10.1016/j.urolonc.2026.111093.